Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore ...

For Nifty-50 index, 23,270 and 23,100 would act as key support zones, while the 50-day SMA, 23,810 and 23,900 could be the ...

The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

Tata Chemicals Ltd on Monday (February 3) reported a net loss of ₹21 crore for the third quarter against a net profit of ₹194 ...

EBITDA jumped 30% to ₹151.8 crore in the third quarter of this fiscal over ₹116.8 crore in the year-ago quarter. Shares of ...